Julie F. Weis

Julie F. Weis, MD, MPH

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Salt Lake City
801-585-0100

  • Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)

  • Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions General Medicine
    Board Certification
    American Board of Internal Medicine (Internal Medicine)

    Education history

    Post Graduate Training HIV Medicine Pathway for Residents - University of Washington School of Medicine Postgraduate Training
    Internal Medicine - University of Washington School of Medicine Resident
    Internship Internal Medicine - University of Washington School of Medicine Intern
    Medicine - University of Utah School of Medicine M.D.
    Graduate Training Public Health Genetics - University of Washington School of Public Health M.P.H.
    Molecular and Cellular Biology - University of Puget Sound B.S.

    Selected Publications

    Journal Article

    1. Lillis L, Lehman DA, Siverson JB, Weis J, Cantera J, Parker M, Piepenburg O, Overbaugh J, Boyle DS (2016). Cross-subtype detection of HIV-1 using reverse transcription and recombinase polymerase amplification. J Virol Methods, 230, 28-35. (Read full article)
    2. Weis JF, Baeten JM, McCoy CO, Warth C, Donnell D, Thomas KK, Hendrix CW, Marzinke MA, Mugo N, Matsen FA IV, Celum C, Lehman DA, Partners PrEP Study Team (2016). Preexposure prophylaxis-selected drug resistance decays rapidly after drug cessation. AIDS, 30(1), 31-5. (Read full article)
    3. Williams KL, Cortez V, Dingens AS, Gach JS, Rainwater S, Weis JF, Chen X, Spearman P, Forthal DN, Overbaugh J (2015). HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans. EBioMedicine, 2(10), 1464-77. (Read full article)
    4. Lehman DA, Baeten JM, McCoy CO, Weis JF, Peterson D, Mbara G, Donnell D, Thomas KK, Hendrix CW, Marzinke MA, Frenkel L, Ndase P, Mugo NR, Celum C, Overbaugh J, Matsen FA, Partners PrEP Study Team (2015). Risk of drug resistance among persons acquiring HIV within a randomized clinical trial of single- or dual-agent preexposure prophylaxis. J Infect Dis, 211(8), 1211-8. (Read full article)
    5. Weis JF, McClelland RS, Jaoko W, Mandaliya KN, Overbaugh J, Graham SM (2014). Short communication: Fc gamma receptors IIa and IIIa genetic polymorphisms do not predict HIV-1 disease progression in Kenyan women. AIDS Res Hum Retroviruses, 31(3), 288-92. (Read full article)
    6. Pagarigan KT, Bunn BW, Goodchild J, Rahe TK, Weis JF, Saucedo LJ (2013). Drosophila PRL-1 is a growth inhibitor that counteracts the function of the Src oncogene. PLoS One, 8(4), e61084. (Read full article)

  • News & Podcasts